| Socio-demographic and other risk factors of pre eclampsia at a tertiary care hospital, karnataka: case control study K Ramesh, S Gandhi, V Rao Journal of clinical and diagnostic research: JCDR 8 (9), JC01, 2014 | 101 | 2014 |
| Anorectal pressures measured with high‐resolution manometry in healthy people—Normal values and asymptomatic pelvic floor dysfunction NR Oblizajek, S Gandhi, M Sharma, S Chakraborty, A Muthyala, ... Neurogastroenterology & Motility 31 (7), e13597, 2019 | 90 | 2019 |
| Somatic symptoms, perceived stress and perceived job satisfaction among nurses working in an Indian psychiatric hospital S Gandhi, G Sangeetha, N Ahmed, SK Chaturvedi Asian journal of psychiatry 12, 77-81, 2014 | 49 | 2014 |
| Psychological preparedness for pandemic (COVID-19) management: Perceptions of nurses and nursing students in India S Gandhi, M Sahu, R Govindan, P Nattala, S Gandhi, PM Sudhir, ... PLoS One 16 (8), e0255772, 2021 | 38 | 2021 |
| Clinical profile of human immunodeficiency virus patients with opportunistic infections: A descriptive case series study K Ramesh, S Gandhi, V Rao International Journal of Applied and Basic Medical Research 5 (2), 119-123, 2015 | 31 | 2015 |
| Elevated serum lactate in patients with lymphoma: it is not always infection GJ Ruan, S Gandhi, JP Abeykoon, S Schram, TM Habermann, ... Mayo Clinic Proceedings: Innovations, Quality & Outcomes 5 (2), 423-430, 2021 | 13 | 2021 |
| Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience M Melody, S Gandhi, H Saunders, Z Abdel-Rahman, J Hastings, ... Leukemia & Lymphoma 63 (6), 1363-1368, 2022 | 7 | 2022 |
| Peak lymphocyte count after CAR T infusion is a clinically accessible test that correlates with clinical response in axicabtagene ciloleucel therapy for lymphoma M Novo, MH Sidiqi, J Paludo, S Gandhi, J Kubusek, T Truong, J Hayne, ... Blood 134, 4106, 2019 | 7 | 2019 |
| Prevalence and risk of progressive aortic aneurysm and dissection in adults with conotruncal anomalies AC Egbe, WR Miranda, CR Bonnichsen, CC Jain, JA Crestanello, ... European Heart Journal-Cardiovascular Imaging 23 (12), 1663-1668, 2022 | 5 | 2022 |
| Impact of rituximab and corticosteroids on late cytopenias post-chimeric antigen receptor T cell therapy M Iqbal, R Bansal, F Yassine, S Gandhi, A Rosenthal, MA Moustafa, Z Li, ... Transplantation and Cellular Therapy 28 (10), 668. e1-668. e6, 2022 | 5 | 2022 |
| Lines of therapy before autologous stem cell transplant and CAR-T affect outcomes in aggressive Non-Hodgkin's lymphoma A Khurana, M Hathcock, TM Habermann, AS Al Saleh, S Gandhi, ... American journal of hematology 96 (10), E386-E389, 2021 | 4 | 2021 |
| Impact of hypoalbuminemia on the prognosis of relapsed/refractory B‐cell lymphoma treated with axicabtagene ciloleucel M Melody, S Gandhi, ZA Rahman, P Lengerke‐Diaz, N Gannon, ... European Journal of Haematology 107 (1), 48-53, 2021 | 4 | 2021 |
| Elevated serum lactate in lymphoma: Not always infection. S Gandhi, PA Pophali, TE Witzig Journal of Clinical Oncology 37 (15_suppl), e19039-e19039, 2019 | 4 | 2019 |
| Response to Bridging Therapy (BT) before CAR-T Cell Infusion Predicts Outcomes for Relapsed/Refractory (R/R) Aggressive B-Cell Non-Hodgkin Lymphoma (NHL) A Khurana, AS Al Saleh, S Gandhi, T Truong, NN Bennani, J Paludo, ... 2021 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2021 | 3 | 2021 |
| Risk of thrombosis in CAR T-cell therapy recipients M Melody, S Gandhi, H Saunders, Z Abdel-Rahman, J Hastings, PL Diaz, ... 2021 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2021 | 3 | 2021 |
| Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin's Lymphoma (NHL) A Khurana, MA Hathcock, TM Habermann, AS Al Saleh, S Gandhi, ... Blood 136, 29-30, 2020 | 3 | 2020 |
| Central nervous system involvement in peripheral t-cell lymphoma S Gandhi, NN Bennani, S Fortin, TM Habermann, P Johnston, JR Cerhan, ... Blood 134, 5293, 2019 | 2 | 2019 |
| Association of lymphocyte to monocyte ratio with clinical response and survival in patients with relapsed, aggressive non-Hodgkin lymphoma treated with axicabtagene ciloleucel … AS Al Saleh, S Gandhi, T Truong, A Khurana, E Brandes, B Estby, ... Journal of Clinical Oncology 38 (15_suppl), 3028-3028, 2020 | 1 | 2020 |
| Impact of type of salvage therapy (ST) and response to bridging therapy (BT) on CAR-T therapy outcomes for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (NHL). A Khurana, AS Al Saleh, S Gandhi, T Truong, E Brandes, B Estby, ... Journal of Clinical Oncology 38 (15_suppl), e15020-e15020, 2020 | 1 | 2020 |
| Baseline Hypoalbuminemia Does Not Appear to Be an Adverse Prognostic Factor in Patients with Relapse/Refractory B-Cell Lymphomas Treated with Axicabtagene Ciloleucel (Axi-cel) M Melody, S Gandhi, ZA Rahman, PAL Diaz, N Gannon, AC Rosenthal, ... Blood 134, 5343, 2019 | 1 | 2019 |
